Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hazen LA"'
Autor:
Yilmaz EC; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Harmon SA; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Law YM; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Huang EP; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Belue MJ; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Lin Y; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Gelikman DG; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Ozyoruk KB; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Yang D; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Xu Z; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Tetreault J; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Xu D; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Hazen LA; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Garcia C; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Lay NS; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Eclarinal P; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Toubaji A; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Merino MJ; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Wood BJ; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Gurram S; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Choyke PL; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Pinto PA; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.)., Turkbey B; From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.).
Publikováno v:
Radiology. Imaging cancer [Radiol Imaging Cancer] 2024 Nov; Vol. 6 (6), pp. e240050.
Autor:
Borde T; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive, Room 3N320, MSC 1182, Bethesda, MD, 20892, USA. tabea.borde@nih.gov., Saccenti L; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive, Room 3N320, MSC 1182, Bethesda, MD, 20892, USA.; Henri Mondor Biomedical Research Institute, Inserm U955, Team N°18, Créteil, France., Li M; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive, Room 3N320, MSC 1182, Bethesda, MD, 20892, USA., Varble NA; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive, Room 3N320, MSC 1182, Bethesda, MD, 20892, USA.; Philips Healthcare, Cambridge, MA, 02141, USA., Hazen LA; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive, Room 3N320, MSC 1182, Bethesda, MD, 20892, USA., Kassin MT; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive, Room 3N320, MSC 1182, Bethesda, MD, 20892, USA., Ukeh IN; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive, Room 3N320, MSC 1182, Bethesda, MD, 20892, USA., Horton KM; Department of Radiology, Georgetown Medical School, Medstar Washington Hospital Center, Washington, DC, 20007, USA., Delgado JF; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive, Room 3N320, MSC 1182, Bethesda, MD, 20892, USA.; Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA., Martin C 3rd; Department of Interventional Radiology, Cleveland Clinic, Cleveland, OH, 44195, USA., Xu S; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive, Room 3N320, MSC 1182, Bethesda, MD, 20892, USA., Pritchard WF; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive, Room 3N320, MSC 1182, Bethesda, MD, 20892, USA., Karanian JW; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive, Room 3N320, MSC 1182, Bethesda, MD, 20892, USA., Wood BJ; Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Drive, Room 3N320, MSC 1182, Bethesda, MD, 20892, USA. bwood@nih.gov.; Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA. bwood@nih.gov.
Publikováno v:
International journal of computer assisted radiology and surgery [Int J Comput Assist Radiol Surg] 2024 May 30. Date of Electronic Publication: 2024 May 30.
Autor:
Anibal JT; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 10 Center Dr, Building 10, Room 1C341, MSC 1182, Bethesda, MD 20892-1182 USA.; Computational Health Informatics Lab, Oxford Institute of Biomedical Engineering, University of Oxford, Old Road Campus Research Building, Headington, Oxford OX3 7DQ, United Kingdom., Landa AJ; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 10 Center Dr, Building 10, Room 1C341, MSC 1182, Bethesda, MD 20892-1182 USA., Hang NTT; Oxford University Clinical Research Unit, Centre for Tropical Medicine, Ho Chi Minh City, Vietnam., Song MJ; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 10 Center Dr, Building 10, Room 1C341, MSC 1182, Bethesda, MD 20892-1182 USA., Peltekian AK; Department of Computer Science, McCormick School of Engineering, Northwestern University, Mudd Hall, 2233 Tech Drive, Third Floor, Evanston, IL, 60208 USA., Shin A; National Library of Medicine, National Institutes of Health, 8600 Rockville Pike, Bethesda, MD, 20894., Huth HB; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 10 Center Dr, Building 10, Room 1C341, MSC 1182, Bethesda, MD 20892-1182 USA., Hazen LA; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 10 Center Dr, Building 10, Room 1C341, MSC 1182, Bethesda, MD 20892-1182 USA., Christou AS; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 10 Center Dr, Building 10, Room 1C341, MSC 1182, Bethesda, MD 20892-1182 USA., Rivera J; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 10 Center Dr, Building 10, Room 1C341, MSC 1182, Bethesda, MD 20892-1182 USA., Morhard RA; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 10 Center Dr, Building 10, Room 1C341, MSC 1182, Bethesda, MD 20892-1182 USA., Bagci U; Feinberg School of Medicine, Northwestern University, 420 E Superior St, Chicago, IL 60611 USA., Li M; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 10 Center Dr, Building 10, Room 1C341, MSC 1182, Bethesda, MD 20892-1182 USA., Bensoussan Y; Morsani College of Medicine, University of South Florida, Tampa, FL, USA., Clifton DA; Computational Health Informatics Lab, Oxford Institute of Biomedical Engineering, University of Oxford, Old Road Campus Research Building, Headington, Oxford OX3 7DQ, United Kingdom., Wood BJ; Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 10 Center Dr, Building 10, Room 1C341, MSC 1182, Bethesda, MD 20892-1182 USA.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2024 Mar 27. Date of Electronic Publication: 2024 Mar 27.
Autor:
Lee KH; McGovern Medical School at UTHealth, Houston, Texas; Center for Interventional Oncology, National Institutes of Health, Bethesda, Maryland., Li M; Center for Interventional Oncology, National Institutes of Health, Bethesda, Maryland., Varble N; Center for Interventional Oncology, National Institutes of Health, Bethesda, Maryland; Philips Research North America, Cambridge, Massachusetts., Negussie AH; Center for Interventional Oncology, National Institutes of Health, Bethesda, Maryland., Kassin MT; Center for Interventional Oncology, National Institutes of Health, Bethesda, Maryland., Arrichiello A; Center for Interventional Oncology, National Institutes of Health, Bethesda, Maryland., Carrafiello G; Department of Radiology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy., Hazen LA; Center for Interventional Oncology, National Institutes of Health, Bethesda, Maryland., Wakim PG; Biostatistics and Clinical Epidemiology Service, National Institutes of Health, Bethesda, Maryland., Li X; Biostatistics and Clinical Epidemiology Service, National Institutes of Health, Bethesda, Maryland., Xu S; Center for Interventional Oncology, National Institutes of Health, Bethesda, Maryland., Wood BJ; Center for Interventional Oncology, National Institutes of Health, Bethesda, Maryland. Electronic address: bwood@nih.gov.
Publikováno v:
Journal of vascular and interventional radiology : JVIR [J Vasc Interv Radiol] 2024 Mar; Vol. 35 (3), pp. 452-461.e3. Date of Electronic Publication: 2023 Oct 17.
Autor:
Yilmaz EC; Molecular Imaging Branch, National Cancer Institute, NIH, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892., Lin Y; Molecular Imaging Branch, National Cancer Institute, NIH, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892., Belue MJ; Molecular Imaging Branch, National Cancer Institute, NIH, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892., Harmon SA; Molecular Imaging Branch, National Cancer Institute, NIH, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892., Phelps TE; Molecular Imaging Branch, National Cancer Institute, NIH, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892., Merriman KM; Molecular Imaging Branch, National Cancer Institute, NIH, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892., Hazen LA; Center for Interventional Oncology, National Cancer Institute, NIH, Bethesda, MD.; Department of Radiology, Clinical Center, NIH, Bethesda, MD., Garcia C; Center for Interventional Oncology, National Cancer Institute, NIH, Bethesda, MD.; Department of Radiology, Clinical Center, NIH, Bethesda, MD., Johnson L; Molecular Imaging Branch, National Cancer Institute, NIH, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892., Lay NS; Molecular Imaging Branch, National Cancer Institute, NIH, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892., Toubaji A; Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD., Merino MJ; Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD., Patel KR; Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, MD., Parnes HL; Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, MD., Law YM; Department of Radiology, Singapore General Hospital, Singapore., Wood BJ; Center for Interventional Oncology, National Cancer Institute, NIH, Bethesda, MD.; Department of Radiology, Clinical Center, NIH, Bethesda, MD., Gurram S; Urologic Oncology Branch, National Cancer Institute, NIH, Bethesda, MD., Choyke PL; Molecular Imaging Branch, National Cancer Institute, NIH, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892., Pinto PA; Urologic Oncology Branch, National Cancer Institute, NIH, Bethesda, MD., Turkbey B; Molecular Imaging Branch, National Cancer Institute, NIH, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892.
Publikováno v:
AJR. American journal of roentgenology [AJR Am J Roentgenol] 2024 Jan; Vol. 222 (1), pp. e2329964. Date of Electronic Publication: 2023 Sep 20.
Autor:
Yilmaz EC; From the Molecular Imaging Branch (E.C.Y., M.J.B., S.A.H., T.E.P., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (J.H.S.), Center for Interventional Oncology (C.G., L.A.H., B.J.W.), Department of Radiology, Clinical Center (C.G., L.A.H., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892., Shih JH; From the Molecular Imaging Branch (E.C.Y., M.J.B., S.A.H., T.E.P., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (J.H.S.), Center for Interventional Oncology (C.G., L.A.H., B.J.W.), Department of Radiology, Clinical Center (C.G., L.A.H., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892., Belue MJ; From the Molecular Imaging Branch (E.C.Y., M.J.B., S.A.H., T.E.P., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (J.H.S.), Center for Interventional Oncology (C.G., L.A.H., B.J.W.), Department of Radiology, Clinical Center (C.G., L.A.H., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892., Harmon SA; From the Molecular Imaging Branch (E.C.Y., M.J.B., S.A.H., T.E.P., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (J.H.S.), Center for Interventional Oncology (C.G., L.A.H., B.J.W.), Department of Radiology, Clinical Center (C.G., L.A.H., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892., Phelps TE; From the Molecular Imaging Branch (E.C.Y., M.J.B., S.A.H., T.E.P., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (J.H.S.), Center for Interventional Oncology (C.G., L.A.H., B.J.W.), Department of Radiology, Clinical Center (C.G., L.A.H., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892., Garcia C; From the Molecular Imaging Branch (E.C.Y., M.J.B., S.A.H., T.E.P., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (J.H.S.), Center for Interventional Oncology (C.G., L.A.H., B.J.W.), Department of Radiology, Clinical Center (C.G., L.A.H., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892., Hazen LA; From the Molecular Imaging Branch (E.C.Y., M.J.B., S.A.H., T.E.P., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (J.H.S.), Center for Interventional Oncology (C.G., L.A.H., B.J.W.), Department of Radiology, Clinical Center (C.G., L.A.H., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892., Toubaji A; From the Molecular Imaging Branch (E.C.Y., M.J.B., S.A.H., T.E.P., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (J.H.S.), Center for Interventional Oncology (C.G., L.A.H., B.J.W.), Department of Radiology, Clinical Center (C.G., L.A.H., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892., Merino MJ; From the Molecular Imaging Branch (E.C.Y., M.J.B., S.A.H., T.E.P., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (J.H.S.), Center for Interventional Oncology (C.G., L.A.H., B.J.W.), Department of Radiology, Clinical Center (C.G., L.A.H., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892., Gurram S; From the Molecular Imaging Branch (E.C.Y., M.J.B., S.A.H., T.E.P., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (J.H.S.), Center for Interventional Oncology (C.G., L.A.H., B.J.W.), Department of Radiology, Clinical Center (C.G., L.A.H., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892., Choyke PL; From the Molecular Imaging Branch (E.C.Y., M.J.B., S.A.H., T.E.P., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (J.H.S.), Center for Interventional Oncology (C.G., L.A.H., B.J.W.), Department of Radiology, Clinical Center (C.G., L.A.H., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892., Wood BJ; From the Molecular Imaging Branch (E.C.Y., M.J.B., S.A.H., T.E.P., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (J.H.S.), Center for Interventional Oncology (C.G., L.A.H., B.J.W.), Department of Radiology, Clinical Center (C.G., L.A.H., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892., Pinto PA; From the Molecular Imaging Branch (E.C.Y., M.J.B., S.A.H., T.E.P., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (J.H.S.), Center for Interventional Oncology (C.G., L.A.H., B.J.W.), Department of Radiology, Clinical Center (C.G., L.A.H., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892., Turkbey B; From the Molecular Imaging Branch (E.C.Y., M.J.B., S.A.H., T.E.P., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (J.H.S.), Center for Interventional Oncology (C.G., L.A.H., B.J.W.), Department of Radiology, Clinical Center (C.G., L.A.H., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892.
Publikováno v:
Radiology [Radiology] 2023 May; Vol. 307 (4), pp. e221309. Date of Electronic Publication: 2023 May 02.
Autor:
Phelps TE; Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, MD, USA., Yilmaz EC; Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, MD, USA., Harmon SA; Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, MD, USA., Belue MJ; Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, MD, USA., Shih JH; Biometric Research Program, National Cancer Institute, NIH, Rockville, MD, USA., Garcia C; Center for Interventional Oncology, National Cancer Institute, NIH, Bethesda, MD, USA.; Department of Radiology, Clinical Center, NIH, Bethesda, MD, USA., Hazen LA; Center for Interventional Oncology, National Cancer Institute, NIH, Bethesda, MD, USA.; Department of Radiology, Clinical Center, NIH, Bethesda, MD, USA., Toubaji A; Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD, USA., Merino MJ; Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD, USA., Gurram S; Urologic Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA., Choyke PL; Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, MD, USA., Wood BJ; Center for Interventional Oncology, National Cancer Institute, NIH, Bethesda, MD, USA.; Department of Radiology, Clinical Center, NIH, Bethesda, MD, USA., Pinto PA; Urologic Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA., Turkbey B; Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, MD, USA. turkbeyi@mail.nih.gov.; Molecular Imaging Branch, National Cancer Institute, 10 Center Dr., MSC 1182, Building 10, Room B3B85, Bethesda, MD, 20892-1088, USA. turkbeyi@mail.nih.gov.
Publikováno v:
Abdominal radiology (New York) [Abdom Radiol (NY)] 2023 Mar; Vol. 48 (3), pp. 1079-1089. Date of Electronic Publication: 2022 Dec 17.